Medium-term glycemic control in diabetics before coronary bypass surgery.
The aim of this study was to determine the association between preoperative medium-term (60-90 days) glycemic control, as reflected by glycosylated hemoglobin levels (HbA1c), and the incidence of major complications (mediastinitis, perioperative infarction, heart failure, stroke and kidney failure dialysis) and mortality in diabetic patients undergoing elective coronary artery by-pass graft surgery (CABG). This study suggests that aggressive glycemic control three months before surgery, achieving HbA1c=7% improvement results with less postoperative morbidity and mortality.
Hospital Universitario, Fundación Favaloro, Buenos Aires, Argentina. E-mail:msantos@ffavaloro.org.
José M
JM
Santos
Roberto R
RR
Favaloro
Diego
D
Lowenstein
Hugo
H
Sanabria
Héctor
H
Raffaelli
Alejandro
A
Hershson
D000368:Aged; D001786:Blood Glucose / Q000032:analysis*; D001026:Coronary Artery Bypass / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D017558:Elective Surgical Procedures / Q000401:mortality; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000401:mortality* / Q000517:prevention & control; D057234:Preoperative Period; D013997:Time Factors; D016896:Treatment Outcome
D001786:Blood Glucose; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human
coronary artery by-pass graft surgery; diabetes; glycosylated hemoglobin